Trials / Terminated
TerminatedNCT04150705
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
A Pilot Study of PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of pilot study is to assess the feasibility of FDG-PET/MRI for monitoring rectal cancer disease status in the setting of rectal cancer non-operative management (NOM). Data from this study will be used to guide the design of future clinical trials involving FDG-PET/MRI for rectal cancer NOM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FDG PET/MRI | -All patients will undergo a simultaneous list mode PET and MR acquisition beginning 55-65 minutes after administration of FDG according to a standard weight-based scale. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2019-11-05
- Last updated
- 2023-02-14
- Results posted
- 2023-02-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04150705. Inclusion in this directory is not an endorsement.